Posted 18 months ago by Carole Unkovich
Meningococcal B (Bexsero) rollout
Kia ora koutou
It was wonderful to see so many of you at Wednesday evening’s Meningococcal B vaccine implementation webinar. For those of you who may have missed it, it’s now available on IMAC’s website.
Some great questions were asked, and IMAC will have a FAQ document available on their website from 1 March which provides answers to the key questions.
From 1 March 2023 the Meningococcal B vaccine (Bexsero) will be funded for:
Scheduled programme: No end date |
Scheduled programme: No end date |
||
|
|
||
Catch-up programme: Ends 31 August 2025 |
Catch-up programme: Ends 28 February 2024 |
||
|
All people aged 13-25 in specified close living situations. Two doses funded. |
||
Definitions |
|||
Close living |
Close living is defined in the pharmaceutical schedule as individuals who are currently living in or entering their first year of boarding school hostels, tertiary education halls of residence, military barracks, or prisons. |
||
Catch-up programme age criteria |
As for all vaccines with an upper age limit – if the course is started before that age limit, then the funded course can be completed. For example, if a child has their first dose of Bexsero before their fifth birthday then they are eligible for the full course. |
||
Funding |
|
Scheduled programmes |
|
Catch-up programme |
|
Vaccine Ordering |
|
|
|
Recording & Monitoring |
|
PMS |
|
NIR |
|
AIR |
|
Recalls |
|
Reporting |
|
Resources |
|
Childhood |
|
Close-living |
|
Immunisation Handbook |
|
Schedule Card |
|
If you have any questions about this update, please email Immunisation@health.govt.nz
Ngā mihi
Rachel Mackay
Group Manager Operations
National Immunisation Programme